Physician profile
Jake Bendicion
NPI 1215508551
$1,778.98
in general payments reported to CMS, 2019-2025
10 companies · $143 in 2025
The $143 reported for 2025 was less than what a typical Surgical provider received nationally (typical 2025 total: $146).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2023: $167 · 2024: $1,470 · 2025: $143.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,047 · Travel and Lodging: $732.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,046.89 |
| Travel and Lodging | $732.09 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Goode Surgical INC | $695.99 | 2023-2024 | |
| Arthrex, INC. | $489.90 | 2024 | |
| Ortho Development Corporation | $144.38 | 2023 | |
| Stryker Corporation | $142.63 | 2025 | Mako, Triathlon |
| Amgen INC. | $91.60 | 2024 | |
| Arteriocyte Medical Systems, INC. | $82.70 | 2024 | Magellan |
| Avanos Medical | $68.98 | 2024 | Grpro 2.1 |
| Ossur Americas, INC. | $23.20 | 2024 | Miami J |
| Forte Bio-Pharma LLC | $21.58 | 2024 | Prolate, Nalocet |
| Smith+Nephew, INC. | $18.02 | 2024 | Pico |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jake Bendicion listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.